Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

With a market cap of $18 billion, Moderna is at the forefront of innovative healthcare solutions, pioneering treatments for ...

Novavax shares dropped Tuesday morning after the company slashed its full-year outlook when it announced its third-quarter results.

Yes, you can get your flu and COVID-19 shots at the same time. Don’t call them boosters — they’re not just another dose of last year’s protection. The coronavirus and influenza are escape artists that ...

Invizyne Technologies (IZTC.) has priced its initial public offering to raise $15M in gross proceeds. The biomanufacturing ...

Pfizer-BioNTech, Johnson and Johnson, and Moderna said their vaccines prevented severe illness ... COVID-19 cases in the U.S. beginning in June 2021. Surges in cases in the fall of 2021, even in ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

He estimates COVID-19 vaccine sales next year will fall to ~$2.0B, lower than the $2.6 billion predicted ... Foroohar lowered ...

Moderna has received approval from Canada's health regulator for its respiratory syncytial virus vaccine in adults 60 years of age and older, the vaccine maker said on Friday.

Check out some anticipated series in the video above or the slideshow gallery below, followed by the full list of new Fall season 2024 anime and where to watch them in the U.S. and their ...

Health Canada has approved Moderna’s mRNA vaccine to protect against respiratory ... The virus generally causes outbreaks of ...

The Cambridge-based company’s latest COVID shot was approved three weeks earlier than last year, according to a statement ...